H1B Salary Data

Home › Employers › Enzo Life Sciences, Inc.

Enzo Life Sciences, Inc.: H-1B salaries and sponsorship

Enzo Life Sciences, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $61,963.

Applications (LCAs)3
Certified3
Employer addressFarmingdale, NY
H-1B dependent employerNo
Median offered salary$61,963
Middle half of salaries$57,408–$74,982
10th–90th percentile$54,675–$82,793

Does Enzo Life Sciences, Inc. sponsor H-1B visas?

Enzo Life Sciences, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 14, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Manufacturing Scientist I1$61,963
Associate Manufacturing Scientist1$52,853
Manufacturing Scientist II1$88,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$61,963
FY20262$70,426

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Manufacturing Scientist II$88,000–$90,000
Level II
Farmingdale, NYMay 14, 2026Oct 1, 2026Certified
Associate Manufacturing Scientist$52,853–$58,240
Level II
Farmingdale, NYDec 15, 2025Dec 15, 2025Certified
Manufacturing Scientist I$61,963–$85,000
Level I
Farmingdale, NYApr 26, 2023Oct 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).